Equity Overview
Price & Market Data
Price: $36.11
Daily Change: -$1.58 / 4.38%
Range: $36.07 - $39.99
Market Cap: $1,313,044,736
Volume: 939,550
Performance Metrics
1 Week: 37.78%
1 Month: 31.03%
3 Months: 30.02%
6 Months: 160.7%
1 Year: 150.9%
YTD: 108.4%
Company Details
Employees: 1000
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.